A detailed history of Northwestern Mutual Wealth Management CO transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 209 shares of SRPT stock, worth $25,934. This represents 0.0% of its overall portfolio holdings.

Number of Shares
209
Previous 250 16.4%
Holding current value
$25,934
Previous $39,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$124.33 - $156.75 $5,097 - $6,426
-41 Reduced 16.4%
209 $26,000
Q2 2024

Aug 15, 2024

BUY
$113.33 - $163.85 $22,666 - $32,770
200 Added 400.0%
250 $39,000
Q1 2024

May 15, 2024

BUY
$93.7 - $141.53 $4,685 - $7,076
50 New
50 $6,000
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $744 - $1,100
7 New
7 $0
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $757 - $1,192
10 New
10 $1,000
Q2 2022

Aug 04, 2022

SELL
$62.69 - $88.44 $125 - $176
-2 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$63.15 - $90.42 $126 - $180
2 New
2 $0
Q4 2021

Feb 03, 2022

SELL
$77.28 - $99.42 $4,250 - $5,468
-55 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$65.97 - $92.48 $3,628 - $5,086
55 New
55 $5,000
Q1 2021

May 14, 2021

SELL
$72.25 - $168.95 $45,878 - $107,283
-635 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$93.0 - $171.7 $58,869 - $108,686
633 Added 31650.0%
635 $102,000
Q1 2020

May 08, 2020

SELL
$82.38 - $131.64 $164 - $263
-2 Reduced 50.0%
2 $0
Q4 2019

Feb 13, 2020

BUY
$76.53 - $135.58 $306 - $542
4 New
4 $1,000
Q2 2019

Aug 12, 2019

SELL
$112.21 - $151.95 $336 - $455
-3 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$106.67 - $151.68 $7,466 - $10,617
-70 Reduced 95.89%
3 $0
Q4 2018

Feb 12, 2019

BUY
$97.32 - $148.76 $7,104 - $10,859
73 New
73 $8,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.